A major feature film can cost well over $100 million before marketing even begins. At that level, approving a movie is not simply a creative decision.
It is a financial commitment involving years of production, global distribution, talent deals, advertising, and sometimes hundreds of millions of dollars in total exposure.
That is why studios spend so much time evaluating risk before saying yes.
Understanding how studios evaluate risk before greenlighting expensive feature films reveals how modern Hollywood balances creativity with commercial pressure.
Executives look at everything from audience awareness and franchise history to director track records, international appeal, production costs, tax incentives, and possible streaming value.
The challenge is that none of these signals guarantees success. Warner Bros. released both major hits and expensive disappointments during 2025, demonstrating how unpredictable theatrical performance can remain.
Mickey 17, for example, carried a budget of about $118 million but struggled commercially, despite acclaimed talent behind and in front of the camera.
Greenlighting is therefore less about eliminating risk and more about deciding whether the potential reward justifies it.
Studios Start With the Size of the Financial Exposure
The first question is usually brutally simple: how much can this movie lose?
Production budget is only the beginning.
An expensive feature may also require major marketing spending, backend compensation for talent, visual-effects overages, international distribution costs, and interest or financing expenses.
Theatrical revenue is also shared with cinema operators, meaning a studio does not keep every dollar reported at the box office.
That is why a $130 million movie may need something close to $300 million globally to reach theatrical break-even.
Variety used One Battle After Another as a 2025 example, noting that its production cost exceeded $130 million and that another roughly $70 million went toward promotion.
Studios therefore model several outcomes before approval.
What happens if the film becomes a hit?
What happens if it performs only moderately?
And, most importantly, what happens if audiences simply do not show up?
The larger the downside, the stronger the evidence executives usually want before greenlighting.
Existing IP Can Lower One Type of Risk
A recognizable franchise gives studios information that an original project cannot.
Previous installments reveal audience size, international performance, merchandise demand, streaming engagement, and demographic appeal.
That data can make an expensive sequel easier to justify.
A new Superman film, for example, arrives with decades of brand recognition. An original science-fiction movie must build awareness almost entirely from scratch.
This does not mean franchise projects are automatically safe.
Familiar IP can still fail if audiences dislike the movie, feel exhausted by the property, or believe the new installment adds little value.
Still, studios often consider established brands less uncertain than unknown concepts.
Industry analysts interviewed by Variety have emphasized that post-pandemic audiences often gravitate toward sequels, spin-offs, and other familiar entertainment when deciding which films deserve a theatrical trip.
That built-in awareness becomes especially important when the production budget is enormous.
Star Power and Directors Are Evaluated Like Assets
Studios also examine who is attached to the project.
A major actor can improve awareness, attract international distributors, generate publicity, and make a project easier to market.
Directors matter too.
An acclaimed filmmaker may bring prestige, awards potential, or a loyal audience. But critical reputation does not always equal commercial reliability.
That distinction is crucial.
Bong Joon Ho entered Mickey 17 after the global success and Oscar sweep of Parasite, while Robert Pattinson brought substantial franchise recognition. Yet the film still faced serious theatrical losses.
Similarly, Paul Thomas Anderson and Leonardo DiCaprio gave One Battle After Another enormous creative prestige, but its high cost created a very difficult financial threshold.
Studios therefore look beyond celebrity names.
They ask whether that talent is actually bankable for this particular genre, budget, rating, and target audience.
A famous star can reduce uncertainty.
They cannot remove it.
Audience Demand Is Tested Before the Movie Exists
Modern studios use extensive market research before committing large sums of money.
That can include surveys, concept testing, franchise awareness studies, social-media analysis, historical box-office comparisons, and internal audience data.
The goal is not to predict an exact final gross.
It is to understand whether enough people appear interested to justify the scale of investment.
Genre matters enormously.
A $150 million action movie may have a plausible global audience.
A $150 million adult drama has a much harder economic case because its potential audience may be smaller.
This is where executives compare budget against realistic demand.
A project can be creatively exciting and still be considered financially mispriced.
Recent industry reporting has repeatedly shown how oversized budgets make even respectable box-office totals look disappointing. One Battle After Another generated more than $200 million globally, yet still faced heavy losses because its costs were so high.
Greenlight decisions therefore depend not only on whether audiences may like a movie, but whether enough of them are likely to pay for it.
International Appeal Can Change the Entire Equation
Big-budget films rarely rely on one country.
Studios evaluate whether a project can travel across major international markets.
Action, fantasy, animation, science fiction, and recognizable franchises often perform well globally because much of their appeal is visual.
Dialogue-heavy comedy or culturally specific drama can be harder to export.
Executives may therefore ask whether the movie has internationally recognizable stars, visually marketable spectacle, established IP, or themes that translate easily across regions.
A project with strong overseas potential can justify a larger budget because its addressable market is bigger.
This is also where foreign distribution rights may become useful.
A studio can sell rights in certain territories before release, reducing its own financial exposure.
A24 used this kind of approach with The Smashing Machine, selling foreign rights to limit its losses even though international partners then carried more of the downside when the movie underperformed.
That is risk sharing in practical terms.
Financing Structures Can Make a Risky Movie More Acceptable
Studios do not always fund expensive films entirely by themselves.
Co-financing partners, presales, tax incentives, rebates, and international distribution agreements can reduce the amount of capital directly at risk.
This matters because the same movie can look very different depending on how it is financed.
Imagine a film costing $150 million.
If one company funds all of it, the downside is concentrated.
If outside partners cover part of the budget and production incentives reduce the net cost, the studio’s real exposure may be far lower.
This is why production location can become a financial decision as much as an artistic one.
Tax credits can materially alter the economics of expensive shoots.
Studios may compare several locations before deciding where to film, factoring in crew costs, infrastructure, visual requirements, and government incentives.
A project that appears too risky at its headline budget may become acceptable after financing structures reduce the effective cost.
That financial engineering is rarely visible to audiences, but it can determine whether a film gets made at all.
The Studio Evaluates the Entire Release Ecosystem
An expensive movie is no longer judged only by theatrical box office.
Executives may estimate value from premium video-on-demand, streaming, television licensing, airline rights, home entertainment, merchandising, games, and long-term library usage.
This matters because some films have strategic value beyond ticket sales.
A major franchise movie can support streaming engagement for years.
A prestige film might strengthen awards positioning and relationships with important filmmakers.
A family movie could have unusually strong merchandising potential.
Warner Bros. defended parts of its costly 2025 slate partly on the basis that individual films existed within a broader portfolio, with profitable hits helping offset weaker theatrical performers.
Executives therefore ask a wider question:
“What is this movie worth across its entire lifecycle?”
That is more useful than looking only at opening weekend.
Comparable Films Help Establish a Realistic Range
Hollywood relies heavily on “comps,” or comparable films.
Executives look at projects with similar genre, budget, audience, stars, rating, release period, and intellectual-property status.
A new original sci-fi film might be compared with several recent original sci-fi releases rather than with a Marvel blockbuster.
This helps studios establish a realistic performance range.
If comparable movies generally earn between $80 million and $150 million worldwide, greenlighting a $180 million production would require an unusually strong justification.
The method is imperfect because every film is different.
Timing changes.
Audience tastes move.
Competitors shift their release dates.
A surprise cultural phenomenon can outperform every comparable title.
Still, comps give decision-makers a more disciplined starting point than pure optimism.
They force executives to confront an uncomfortable but useful question: has this type of movie ever supported this level of spending before?
Release Timing and Competition Affect the Greenlight Case
Studios also evaluate where a project might fit into the future calendar.
A huge movie needs enough space to breathe.
Opening directly against another blockbuster can reduce premium screens, marketing attention, and audience availability.
Executives therefore study school holidays, summer periods, major franchises already dated by competitors, sporting events, and seasonal genre patterns.
The release calendar can even affect the budget a studio is comfortable approving.
A movie with a strong holiday slot and little direct competition may support a more aggressive investment.
One arriving in a crowded period may need tighter spending.
Timing is especially difficult because expensive features are often approved years before release.
The competitive landscape can change dramatically during production.
That uncertainty means studios need some flexibility in both scheduling and marketing.
A good greenlight decision is therefore not only about the film itself.
It is also about the environment into which the film will eventually arrive.
Studios Run Downside Scenarios Before Saying Yes
Perhaps the most important part of risk evaluation is scenario planning.
Executives rarely assume the optimistic forecast will happen.
They model several outcomes.
A best-case scenario may show a global hit with strong ancillary revenue.
A base case estimates a more normal result.
A downside case asks what happens if reviews are weak, word of mouth collapses, international markets underperform, or the opening weekend disappoints.
This is where budget discipline becomes critical.
A leaner movie may remain survivable even under a poor scenario.
An oversized production can become a disaster.
Variety’s analysis of 2025 theatrical disappointments repeatedly highlighted this issue. Lower-budget films such as Roofman could absorb modest box-office results more easily, while projects costing above $100 million faced much more painful losses.
Studios are essentially asking: “If almost everything goes wrong, can we live with the result?”
If the answer is no, the project may need a smaller budget, a financing partner, or no greenlight at all.
Creative Value Still Matters
Hollywood greenlighting is not purely mathematical.
If it were, studios would never take creative risks.
Executives may approve projects because they believe strongly in a filmmaker, see awards potential, want to build relationships with talent, or think an unusual idea could become a major cultural event.
Warner Bros.’ 2025 slate demonstrates this tension particularly clearly.
The studio backed expensive original filmmakers, suffering losses on some projects while also finding significant success with movies such as Sinners and Weapons.
This is why greenlighting ultimately combines data with judgment.
Numbers can identify risks.
They cannot perfectly measure cultural impact.
A studio that approves only the safest possible projects may avoid certain losses but also miss the next unexpected hit.
The skill is not eliminating creative risk.
It is taking that risk at a price the business can survive.
Studios evaluate risk before greenlighting expensive feature films by looking at far more than the script.
Budget size, franchise strength, star power, audience demand, international potential, financing, release timing, comparable films, and downstream revenue all contribute to the decision.
Even then, certainty is impossible.
Recent expensive successes and failures show that famous talent, critical acclaim, and recognizable brands can improve the odds without guaranteeing a commercial win.
The best studios therefore focus on disciplined risk rather than perfect prediction. They ask whether the upside is meaningful, whether the downside is survivable, and whether the budget matches the realistic size of the audience.
Next time you see a $150 million movie announcement, look beyond the headline number. The real story is the complex risk calculation that convinced executives to make the bet.
